New analysis of supermarket purchasing patterns reveals a striking disconnect between clinical effectiveness and consumer choices in menstrual pain relief. Approximately 70% of women experience period pain, yet supermarket data indicates many are selecting paracetamol-based treatments despite evidence showing NSAIDs like ibuprofen are 85% effective compared to just 35% for paracetamol alone. Combined therapy approaches achieve 70% effectiveness, offering an intermediate option. These figures underscore a critical education gap in pain management. When women understand that anti-inflammatory medications address the root inflammatory cause of menstrual cramps rather than simply reducing pain sensation, they may make more informed treatment decisions. The data suggests that retail pharmacy marketing may be influencing purchases more than clinical guidance, resulting in prolonged discomfort for millions of women each month. Read the full article on GMJ Newsroom.
Was this article helpful?
